Zobrazeno 1 - 10
of 210
pro vyhledávání: '"Vivek N. Iyer"'
Autor:
Ciara C. O’Sullivan, Alexandra S. Higgins, Adham K. Alkurashi, Vaibhav Ahluwalia, Jodi L. Taraba, Paul M. McKie, Patrick S. Kamath, Vivek N. Iyer, Tufia C. Haddad
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
BackgroundThe advent of antibody-drug conjugates (ADCs) represents a landmark advance in cancer therapy, permitting targeted delivery of a potent cytotoxic agent to tumor cells with minimal damage to surrounding cells. Although ADCs can induce sustai
Externí odkaz:
https://doaj.org/article/17cffb39203f42398b030ad1b66626b6
Autor:
Arshia K. Sethi, Pratyusha Muddaloor, Priyanka Anvekar, Joshika Agarwal, Anmol Mohan, Mansunderbir Singh, Keerthy Gopalakrishnan, Ashima Yadav, Aakriti Adhikari, Devanshi Damani, Kanchan Kulkarni, Christopher A. Aakre, Alexander J. Ryu, Vivek N. Iyer, Shivaram P. Arunachalam
Publikováno v:
Sensors, Vol 23, Iss 12, p 5514 (2023)
Respiratory disorders, being one of the leading causes of disability worldwide, account for constant evolution in management technologies, resulting in the incorporation of artificial intelligence (AI) in the recording and analysis of lung sounds to
Externí odkaz:
https://doaj.org/article/0d625b9be0c74544be2353432e751643
Autor:
Hasan Ahmad Hasan Albitar, MD, Holly Van Houten, BA, Lindsey R. Sangaralingham, MPH, Meghan Knoedler, MS, Yahya Almodallal, MBBS, Adham K. Alkurashi, MBBS, Alice Gallo De Moraes, MD, Hector Cajigas, MD, Hillary DuBrock, MD, Deepti Warad, MBBS, Nadir Demirel, MD, Michael Krowka, MD, Waleed Brinjikji, MD, Vivek N. Iyer, MD, MPH
Publikováno v:
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 5, Iss 1, Pp 55-64 (2021)
Objective: To assess the health care costs and utilization in patients with hereditary hemorrhagic telangiectasia (HHT) in the United States. Patients and Methods: Retrospective analysis of patients with HHT diagnosed between 2007 and 2017 was perfor
Externí odkaz:
https://doaj.org/article/974faeac1136453ba9e0bc4fc3958580
Publikováno v:
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 4, Iss 4, Pp 460-463 (2020)
Bevacizumab is now an emerging treatment option for severe hereditary hemorrhagic telangiectasia–related bleeding including epistaxis and gastrointestinal tract bleeding. The impact of long-term intravenous bevacizumab therapy on cardiac structure
Externí odkaz:
https://doaj.org/article/795680b1f4a94be2954797178072947b
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 14, Iss 1, Pp 1-7 (2019)
Abstract Background Systemic bevacizumab is a novel targeted anti-angiogenic therapy for high-output cardiac failure (HOCF) in hereditary hemorrhagic telangiectasia (HHT) but published data is limited. This survey-based study measured physician-repor
Externí odkaz:
https://doaj.org/article/a13e6bcb08d144d589427e5835c793f3
Autor:
Nitin Abrol, MBBS, MCh, Rahul Kashyap, MBBS, Ryan D. Frank, MS, Vivek N. Iyer, MD, Patrick G. Dean, MD, Mark D. Stegall, MD, Mikel Prieto, MD, Kianoush B. Kashani, MD, MS, Timucin Taner, MD, PhD
Publikováno v:
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 3, Iss 3, Pp 285-293 (2019)
Objective: To identify preoperative factors predicting early admission (within 30 days) of adult kidney transplant recipients to the intensive care unit (ICU). Patients and Methods: This is a single-center retrospective study of consecutive kidney tr
Externí odkaz:
https://doaj.org/article/e018a18637a840a69fd6549ab4841b2f
Autor:
Hanny Al-Samkari, Raj S. Kasthuri, Joseph G. Parambil, Hasan A. Albitar, Yahya A. Almodallal, Carolina Vázquez, Marcelo M. Serra, Sophie Dupuis-Girod, Craig B. Wilsen, Justin P. McWilliams, Evan H. Fountain, James R. Gossage, Clifford R. Weiss, Muhammad A. Latif, Assaf Issachar, Meir Mei-Zahav, Mary E. Meek, Miles Conrad, Josanna Rodriguez-Lopez, David J. Kuter, Vivek N. Iyer
Publikováno v:
Haematologica, Vol 106, Iss 8 (2020)
Hereditary hemorrhagic telangiectasia (HHT, Osler-Weber-Rendu disease) is a rare multisystem vascular disorder causing chronic gastrointestinal bleeding, epistaxis, and severe anemia. Bevacizumab, an anti-vascular endothelial growth factor antibody,
Externí odkaz:
https://doaj.org/article/5212c2e98ac741cb90e807f30327a909
Publikováno v:
Respiratory Medicine Case Reports, Vol 31, Iss , Pp 101178- (2020)
Background: Hypereosinophilia (HE) is defined by the presence of >1.5 × 109/L eosinophils in the peripheral blood. Paraneoplastic HE has been reported in a number of solid and hematologic malignancies including ovarian cancer. We present a case with
Externí odkaz:
https://doaj.org/article/e54dd6f28cf642b6a22a5c717f3ea3a5
Publikováno v:
Respiratory Medicine Case Reports, Vol 31, Iss , Pp 101277- (2020)
Pneumocystis pneumonia affects immunocompromised hosts. The typical imaging finding is bilateral diffuse ground glass opacities. Here we presented a case of Pneumocystis causing biopsy-confirmed cavitary lung lesions in a patient with a predominant B
Externí odkaz:
https://doaj.org/article/ff4243cfe33340ac87b6476ad4fef067
Publikováno v:
Respiratory Medicine Case Reports, Vol 30, Iss , Pp 101117- (2020)
Background: While chemotherapeutic agents result in an improvement in both disease-free and overall survival in cancer patients, treatment can result in short and long-term complications. One well-known complication is neuropathy which can result fro
Externí odkaz:
https://doaj.org/article/962ac5a57ad246e29fa097786b546f8f